Glaucoma affects approximately 65 million people around the world and an expected 7.5 million are blind due to the disease. It is the second most common cause of blindness worldwide.1 It is estimated that perhaps half the blindness from glaucoma in the world is caused by angle closure.2 Accordingly, in order to be effective, any case detection has to include methods to detect angle closure.
A clinic examination is different from a screening programme in the community. In the clinic the patient has sought us out and the responsibility is ours to detect and treat any pathology, including glaucoma. Some short cuts that may be satisfactory in screening programmes are not acceptable in a clinic. The best method to detect (and assess) glaucoma is to perform a comprehensive eye examination for all patients who attend the clinic, irrespective of the complaints they present with.3
[1]
E. E. Hartmann,et al.
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
,
2002,
Archives of ophthalmology.
[2]
H. Quigley.
Number of people with glaucoma worldwide.
,
1996,
The British journal of ophthalmology.
[3]
G. Johnson,et al.
The Burden of Trachoma in the Rural Nile Delta of Egypt : a Survey of Menofiya Governorate The Epidemiology of Ocular Trauma in Singapore : Perspective from the Emergency Service of a Large Tertiary Hospital
,
2005
.
[4]
P. Paul,et al.
Population-based screening versus case detection.
,
2002,
Indian journal of ophthalmology.